Stockscreener 앱 받기
15.72
1.09%
0.17
시장 영업 전:
16.04
0.32
+2.04%
전일 마감가:
$15.55
열려 있는:
$16.05
하루 거래량:
1.27M
Relative Volume:
0.97
시가총액:
$1.45B
수익:
$2.98B
순이익/손실:
$-300.00M
주가수익비율:
-4.6235
EPS:
-3.4
순현금흐름:
$225.00M
1주 성능:
+10.39%
1개월 성능:
+38.62%
6개월 성능:
+150.72%
1년 성능:
-22.45%
1일 변동 폭
$15.43
$16.33
1주일 범위
$14.02
$16.94
52주 변동 폭
$3.97
$20.86
Fortrea Holdings Inc Stock (FTRE) Company Profile
명칭
Fortrea Holdings Inc
전화
877-495-0816
주소
8 MOORE DRIVE, DURHAM
FTRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FTRE
Fortrea Holdings Inc
|
15.72 | 1.44B | 2.98B | -300.00M | 225.00M | -3.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-08-04 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-05-02 | 개시 | Truist | Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-06 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-09-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-08-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-07-24 | 재개 | Barclays | Equal Weight |
| 2024-06-06 | 개시 | Goldman | Neutral |
| 2024-05-29 | 개시 | TD Cowen | Hold |
| 2024-05-28 | 개시 | Mizuho | Neutral |
| 2024-03-22 | 개시 | Robert W. Baird | Neutral |
| 2024-03-06 | 개시 | Deutsche Bank | Hold |
| 2024-01-05 | 개시 | William Blair | Mkt Perform |
| 2024-01-04 | 개시 | Jefferies | Buy |
| 2023-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-12-01 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-11-14 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-19 | 개시 | Citigroup | Neutral |
| 2023-09-14 | 개시 | Evercore ISI | In-line |
| 2023-08-16 | 개시 | Barclays | Equal Weight |
| 2023-08-07 | 개시 | BofA Securities | Underperform |
모두보기
Fortrea Holdings Inc 주식(FTRE)의 최신 뉴스
Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Liquidity Mapping Around (FTRE) Price Events - news.stocktradersdaily.com
Beck Mack & Oliver LLC Sells 916,179 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. ... - Bakersfield.com
Notice to Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire Inc.
Fortrea (NASDAQ:FTRE) Shares Gap UpShould You Buy? - MarketBeat
1,029,700 Shares in Fortrea Holdings Inc. $FTRE Acquired by Bank of Nova Scotia - MarketBeat
Why Fortrea (FTRE) Stock Is Up Today - Finviz
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Important Notice to Long-Term Shareholders of Alexandria - GlobeNewswire
Citigroup Upgrades Fortrea Holdings to Buy From Neutral - marketscreener.com
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Enidnews.com
Fortrea (NASDAQ:FTRE) Shares Up 5.5%Still a Buy? - MarketBeat
Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Kennedy Capital Management LLC Sells 111,459 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat
Attention Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Investors to Connect - ACCESS Newswire
Fortrea Holdings Inc. (NASDAQ:FTRE) Surges 27% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Fortrea Holdings (NASDAQ:FTRE) NASDAQ Index Fund Biopharma Power - Kalkine Media
Fortrea (NASDAQ:FTRE) Stock Price Down 5.7%Time to Sell? - MarketBeat
Fortrea, SCTbio announce strategic collaboration agreement - MSN
How Fortrea Holdings Inc. (K67) stock compares with market leadersMarket Sentiment Report & Technical Pattern Alert System - Newser
What dividend safety score for Fortrea Holdings Inc. stockPortfolio Return Report & Low Risk High Win Rate Picks - Newser
Fortrea Holdings Inc. (NASDAQ:FTRE) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings, Inc. (FTRE) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Will Fortrea Holdings Inc. (K67) stock outperform global peersJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - Newser
Fortrea (NASDAQ:FTRE) Shares Up 10.1%Time to Buy? - MarketBeat
SCTbio and Fortrea forge strategic collaboration to accelerate cell and gene therapy development and delivery - marketscreener.com
Fortrea, SCTbio Collaborate Over Cell, Gene Therapy Development, Delivery - marketscreener.com
SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery - The Globe and Mail
Capital Fund Management S.A. Grows Stake in Fortrea Holdings Inc. $FTRE - MarketBeat
Geode Capital Management LLC Increases Stake in Fortrea Holdings Inc. $FTRE - MarketBeat
Fortrea (FTRE) Valuation Check After Investigation into Alleged Overstated Revenue, Cost Savings, and 2025 EBITDA Targets - Yahoo Finance
Improved Revenues Required Before Fortrea Holdings Inc. (NASDAQ:FTRE) Stock's 26% Jump Looks Justified - 富途牛牛
Brandes Investment Partners LP Acquires 94,448 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat
Is Fortrea Holdings Inc. stock trading at a premium valuationJuly 2025 Gainers & Weekly Return Optimization Alerts - Newser
Fortrea (FTRE) Valuation Check as Legal Probe Questions Revenue Recognition and 2025 EBITDA Targets - simplywall.st
Levi & Korsinsky Notifies Fortrea Holdings Inc. (FTRE) Investors - The National Law Review
Why (FTRE) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Transcript : Fortrea Holdings Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 01 - marketscreener.com
Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire
Will Fortrea Holdings Inc. (K67) stock benefit from sector leadership2025 Big Picture & Low Risk Entry Point Tips - Newser
SG Americas Securities LLC Reduces Position in Fortrea Holdings Inc. $FTRE - MarketBeat
How strong is Fortrea Holdings Inc. stock revenue growthTrade Exit Summary & Real-Time Buy Zone Alerts - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdi - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Stockholders to Connect - ACCESS Newswire
Is Fortrea Holdings Inc. stock a safe haven assetCEO Change & Detailed Earnings Play Strategies - BỘ NỘI VỤ
Envestnet Asset Management Inc. Sells 69,467 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat
Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Can Fortrea Holdings Inc. stock maintain growth trajectory2025 Fundamental Recap & AI Enhanced Trading Signals - moha.gov.vn
Fortrea Holdings Inc (FTRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):